Poirier, John Thomas
- NYU Grossman School of Medicine · Internal Medicine (NIH department code)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
FY2021 NIH rank #6,778
- Program Leader
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2021Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award categories
- Internal Medicine
NIH Funding · FY2021
Linked Award Amount
$1.3M
Full award amounts, FY2021
Award Records
2
Records listing this PI
Award-Linked Rank
#6,778
By linked amount among FY2021 PIs
Earliest Year Loaded
2017
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2021 award records by amount
NIH award records listing Poirier, John Thomas as a PI. Multi-PI records show the full award amount for context.
- 5R01CA213448-05R01Contact PIImmuno-PET imaging of high-grade neuroendocrine lung tumors using 89Zrrovalpituzumab, a DLL3-targeting monoclonal antibodyNYU Grossman School of Medicine · Internal Medicine (NIH department code)$939.8Kaward amount
- 5U01CA213359-05U01Contact PIClinical development of a DLL3-targeted theranostic for small cell lung cancerNYU Grossman School of Medicine · Internal Medicine (NIH department code)$335.4Kaward amount
Award organization
Organizations that administered FY2021 awards listing Poirier, John Thomas as a PI.
FY2021 award administered by NYU Grossman School of Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardNYU Grossman School of Medicine
- 2018$500K Cumulative Funding
- 2018R01 Grant Holder
- 2019$1M Cumulative Funding
- 2019Program/Center Grant Leader
- 2021$2M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #6778